Up­dat­ed: Take­da to re­vamp in mul­ti­year quest, piv­ots CAR-NK ther­a­py from can­cer to au­toim­mune

Take­da is launch­ing a broad, mul­ti­year re­struc­tur­ing, along­side a hand­ful of pipeline cuts, CEO Christophe We­ber an­nounced Thurs­day.

Start­ing this year, Take­da said it will sim­pli­fy the struc­ture of some di­vi­sions, “rig­or­ous­ly pri­or­i­tize its R&D pipeline,” and “op­ti­mize its work­force.” Ex­ec­u­tives added that Take­da will al­so in­vest in da­ta, dig­i­tal and tech­nol­o­gy, and find ways to make its sup­ply chain and ven­dor man­age­ment process­es more ef­fi­cient.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER